Sectors
APRE
Aprea Therapeutics, Inc.
0.80
1 x 0.79
2 x 0.86
bid
ask
-
0.04
4.60%
2 @ 04:00 PM
0.80 -0.00 (0.53%)
| Ytd | -6.21% | |
| 1y | -49.04% |
0.78
day range
0.85
0.55
52 week range
1.69
| Open | 0.85 | Prev Close | 0.84 | Low | 0.78 | High | 0.85 | Mkt Cap | 10.07M |
| Vol | 475.73K | Avg Vol | 217.11K | EPS | -0.94 | P/E | N/A | Forward P/E | -3.08 |
| Beta | 1.74 | Short Ratio | 0.55 | Inst. Own | 43.85% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 0.71 | 200-d Avg | 0.83 | 1yr Est | 15.67 |
| Income Statement | |||
| Operating Expenses | 4.03M | ||
| Research and Development Expense | 2.46M | ||
| Selling, General and Administrative Expense | 1.57M | ||
| Operating Income | -4.03M | ||
| Net Income | -3.59M | ||
| Net Income Common Stock | -3.59M | ||
| Net Income Common Stock (USD) | -3.59M | ||
| Consolidated Income | -3.59M | ||
| Earnings per Basic Share | -0.07 | ||
| Earnings per Basic Share (USD) | -0.07 | ||
| Earnings per Diluted Share | -0.07 | ||
| Earning Before Interest & Taxes (EBIT) | -3.59M | ||
| Earning Before Interest & Taxes (USD) | -3.59M | ||
| Weighted Average Shares | 53.48M | ||
| Weighted Average Shares Diluted | 53.48M | ||
| Balance Sheet | |||
| Cash and Equivalents | 41.28M | ||
| Cash and Equivalents (USD) | 41.28M | ||
| Current Assets | 41.91M | ||
| Property, Plant & Equipment Net | 64.03K | ||
| Total Assets | 42.29M | ||
| Current Liabilities | 3.09M | ||
| Total Liabilities | 3.82M | ||
| Accumulated Retained Earnings (Deficit) | -340.52M | ||
| Accumulated Other Comprehensive Income | -10.62M | ||
| Shareholders Equity | 38.47M | ||
| Shareholders Equity (USD) | 38.47M | ||
| Assets Non-Current | 376.81K | ||
| Liabilities Non-Current | 727.36K | ||
| Trade and Non-Trade Payables | 935.14K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 5.75K | ||
| Net Cash Flow from Financing | -1.94M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -5.23M | ||
| Issuance (Purchase) of Equity Shares | -1.94M | ||
| Net Cash Flow from Operations | -3.28M | ||
| Effect of Exchange Rate Changes on Cash | -695.00 | ||
| Share Based Compensation | 103.19K | ||